Eligibility Rheumatoid Arthritis NCT01034397

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >/=18 years of age
Descrizione

ID.1

Tipo di dati

boolean

moderate to severe rheumatoid arthritis of >/=6 months duration
Descrizione

ID.2

Tipo di dati

boolean

synovitis (swollen and tender joint) in the wrist of the dominant hand
Descrizione

ID.3

Tipo di dati

boolean

non-biologic dmards at stable dose for >/=12 weeks prior to baseline
Descrizione

ID.4

Tipo di dati

boolean

oral corticosteroids at stable dose for at least 25 out of 28 days prior to baseline
Descrizione

ID.5

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
rheumatic autoimmune disease other than ra
Descrizione

ID.6

Tipo di dati

boolean

history of or current inflammatory joint disease other than ra
Descrizione

ID.7

Tipo di dati

boolean

functional class iv (acr classification)
Descrizione

ID.8

Tipo di dati

boolean

intraarticular or parenteral corticosteroids within 6 weeks prior to baseline
Descrizione

ID.9

Tipo di dati

boolean

previous treatment with a biologic agent for ra
Descrizione

ID.10

Tipo di dati

boolean

Similar models

Eligibility Rheumatoid Arthritis NCT01034397

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
adult patients, >/=18 years of age
boolean
ID.2
Item
moderate to severe rheumatoid arthritis of >/=6 months duration
boolean
ID.3
Item
synovitis (swollen and tender joint) in the wrist of the dominant hand
boolean
ID.4
Item
non-biologic dmards at stable dose for >/=12 weeks prior to baseline
boolean
ID.5
Item
oral corticosteroids at stable dose for at least 25 out of 28 days prior to baseline
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
rheumatic autoimmune disease other than ra
boolean
ID.7
Item
history of or current inflammatory joint disease other than ra
boolean
ID.8
Item
functional class iv (acr classification)
boolean
ID.9
Item
intraarticular or parenteral corticosteroids within 6 weeks prior to baseline
boolean
ID.10
Item
previous treatment with a biologic agent for ra
boolean